Bionano Genomics to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
September 07 2022 - 4:30PM
Bionano Genomics, Inc. (BNGO) announced today that company
management will participate virtually at the H.C. Wainwright 24th
Annual Global Annual Global Investment Conference, taking
place September 12-14, 2022. A pre-recorded presentation will be
available on the Investor Resources page of the Company's
website on Monday, September 12 at 7:00 am ET.
About Bionano Genomics
Bionano Genomics is a provider of genome analysis solutions
that can enable researchers and clinicians to reveal answers to
challenging questions in biology and medicine. The Company’s
mission is to transform the way the world sees the genome through
optical genome mapping (OGM) solutions, diagnostic services and
software. The Company offers OGM solutions for applications across
basic, translational and clinical research. Through
its Lineagen business, the Company also provides
diagnostic testing for patients with clinical presentations
consistent with autism spectrum disorder and other
neurodevelopmental disabilities. Through its BioDiscovery business,
the Company also offers an industry-leading, platform-agnostic
software solution, which integrates next-generation sequencing and
microarray data designed to provide analysis, visualization,
interpretation and reporting of copy number variants, single
nucleotide variants and absence of heterozygosity across the genome
in one consolidated view.
For more information,
visit www.bionanogenomics.com, www.lineagen.com or www.biodiscovery.com
CONTACTSCompany Contact:Erik Holmlin,
CEOBionano Genomics, Inc.+1 (858)
888-7610eholmlin@bionanogenomics.com
Investor Relations:Amy ConradJuniper Point+1 (858)
366-3243amy@juniper-point.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Apr 2023 to Apr 2024